DLeader (dleader.co.jp): no confident changes recorded yet; website history since November 2026. Homepage last checked 6 November 2026.
First recorded website
Observed 6 November 2026
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Accelerating RNA Therapeutics with AI
KumiChem is DLeader's agentic AI platform for RNA drug discovery — ASO and siRNA design, in silico toxicity screening, and data-driven candidate prioritization, from a simple prompt to a validated can
Homepage
Displayed as investors on the website
AWS Activate · Google for Startups · The University of Osaka · Institute for Protein Research · Life Intelligence Consortium · HVC KYOTO · JETRO · First Domino · Friends Corp.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
Recorded changes
Newest observations first. Each interval bounds when the website changed; it is not an exact event date.
No changes recorded yet. Missing observations do not mean the company has not changed.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messagingAccelerating RNA Therapeutics with AI
KumiChem is DLeader's agentic AI platform for RNA drug discovery — ASO and siRNA design, in silico toxicity screening, and data-driven candidate prioritization, from a simple prompt to a validated can